Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway.
Nature Communications
González, Lorena L; Díaz, Lucía L; Pous, Joan J; Baginski, Blazej B; Duran-Corbera, Anna A; Scarpa, Margherita M; Brun-Heath, Isabelle I; Igea, Ana A; Martin-Malpartida, Pau P; Ruiz, Lidia L; Pallara, Chiara C; Esguerra, Mauricio M; Colizzi, Francesco F; Mayor-Ruiz, Cristina C; Biondi, Ricardo M RM; Soliva, Robert R; Macias, Maria J MJ; Orozco, Modesto M; Nebreda, Angel R AR
Effects of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeted combined chemotherapy on immune function, tumor markers and oxidative stress in patients with stage IV lung adenocarcinoma.
Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study.
Advances In Therapy
Molife, Cliff C; Winfree, Katherine B KB; Bailey, Hollie H; D'yachkova, Yulia Y; Forshaw, Cameron C; Kim, Sangmi S; Taipale, Kaisa-Leena KL; Puri, Tarun T
Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer.
Theranostics
Rubio, Karla K; Romero-Olmedo, Addi J AJ; Sarvari, Pouya P; Swaminathan, Guruprasadh G; Ranvir, Vikas P VP; Rogel-Ayala, Diana G DG; Cordero, Julio J; Günther, Stefan S; Mehta, Aditi A; Bassaly, Birgit B; Braubach, Peter P; Wygrecka, Malgorzata M; Gattenlöhner, Stefan S; Tresch, Achim A; Braun, Thomas T; Dobreva, Gergana G; Rivera, Miguel N MN; Singh, Indrabahadur I; Graumann, Johannes J; Barreto, Guillermo G
Retrospective Analysis of the Incidence of Drug-Induced Interstitial Lung Disease by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Survival in Patients Aged 75 Years or Older with Lung Cancer.
Jma Journal
Ishibashi, Masayuki M; Nakagawa, Yoshiko Y; Shimizu, Tetsuo T; Gon, Yasuhiro Y; Yamamoto, Hiroshi H
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer.
Embo Molecular Medicine
Santonja, Angela A; Cooper, Wendy N WN; Eldridge, Matthew D MD; Edwards, Paul A W PAW; Morris, James A JA; Edwards, Abigail R AR; Zhao, Hui H; Heider, Katrin K; Couturier, Dominique-Laurent DL; Vijayaraghavan, Aadhitthya A; Mennea, Paulius P; Ditter, Emma-Jane EJ; Smith, Christopher G CG; Boursnell, Chris C; Manzano García, Raquel R; Rueda, Oscar M OM; Beddowes, Emma E; Biggs, Heather H; Sammut, Stephen-John SJ; Rosenfeld, Nitzan N; Caldas, Carlos C; Abraham, Jean E JE; Gale, Davina D
Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma.
Croatian Medical Journal
Harabajsa, Suzana S; Šefčić, Hajdi H; Klasić, Marija M; Milavić, Marija M; Židovec Lepej, Snježana S; Grgić, Ivana I; Zajc Petranović, Matea M; Jakopović, Marko M; Smojver-Ježek, Silvana S; Korać, Petra P
Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies.
Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines.
Journal Of Enzyme Inhibition And Medicinal Chemistry
Son, Seohyun S; Elkamhawy, Ahmed A; Gul, Anam Rana AR; Al-Karmalawy, Ahmed A AA; Alnajjar, Radwan R; Abdeen, Ahmed A; Ibrahim, Samah F SF; Alshammari, Saud O SO; Alshammari, Qamar A QA; Choi, Won Jun WJ; Park, Tae Jung TJ; Lee, Kyeong K
[A Real-world Study on the Expression Characteristics of PD-L1 in Patients with Advanced EGFR Positive NSCLC and Its Relationship with the Therapeutic Efficacy of EGFR-TKIs].
Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer
Chen, Ran R; Gao, Xiang X; Xu, Fudong F; Zhang, Shucai S; Ma, Li L; Hu, Bo B
Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones.
Journal Of Medicinal Chemistry
Harnden, Alice C AC; Davis, Owen A OA; Box, Gary M GM; Hayes, Angela A; Johnson, Louise D LD; Henley, Alan T AT; de Haven Brandon, Alexis K AK; Valenti, Melanie M; Cheung, Kwai-Ming J KJ; Brennan, Alfie A; Huckvale, Rosemary R; Pierrat, Olivier A OA; Talbot, Rachel R; Bright, Michael D MD; Akpinar, Hafize Aysin HA; Miller, Daniel S J DSJ; Tarantino, Dalia D; Gowan, Sharon S; de Klerk, Selby S; McAndrew, Peter Craig PC; Le Bihan, Yann-Vaï YV; Meniconi, Mirco M; Burke, Rosemary R; Kirkin, Vladimir V; van Montfort, Rob L M RLM; Raynaud, Florence I FI; Rossanese, Olivia W OW; Bellenie, Benjamin R BR; Hoelder, Swen S
Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis.